[Gynecological indications of a new progestational agent with prolonged action]

other public-domain-us
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View on PubMed
AI-generated summary by claude@2026-08, 2026-08-08

This paper describes the gynecological indications for a novel progestational agent exhibiting prolonged action.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Abortion, Threatened Breast Neoplasms Delayed-Action Preparations Genital Diseases, Female Genital Neoplasms, Female Medroxyprogesterone Menstruation Disturbances Abortion, Threatened Adenocarcinoma Adenocarcinoma Adolescent Adult Breast Neoplasms Delayed-Action Preparations Endometriosis Endometriosis Female Genital Diseases, Female Genital Neoplasms, Female Humans

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-08-12T06:07:16.479679+00:00
pubmed
last seen: 2026-05-14T05:59:19.139991+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine